Genuine Parts Company distributes automotive and industrial replacement parts. It operates in two segments, Automotive Parts Group and Industrial Parts Group. The company distributes automotive parts, accessories and solutions and replacement parts for hybrid and electric vehicles, trucks, SUVs, buses, motorcycles, farm equipment, and heavy duty equipment; and equipment parts and technologies. It also offers automotive parts, including brakes, batteries, filters, engine components, tools, accessories, and fluids; custom services, such as paint mixing, hydraulic hose assembly, battery testing, and key cutting; and accessories, tools, and equipment for servicing heavy duty and diesel vehicles, as well as operates service and mechanical repair centers for heavy vehicles. In addition, the company operates independent repair shops and auto care centers under the NAPA brand; and NAPA online, an online platform to browse, purchase, and have automotive products, as well as provides DIY workshops and training sessions to customers. Further, it provides abrasives, adhesives, sealants and tape, bearings, chemicals, cutting tools, electrical, facility maintenance, hose and fittings, hydraulics, janitorial, mechanical power transmission, pneumatics, process pumps and equipment, safety, seals and gaskets, tools and testing instruments, as well as inventory management, asset repair and tracking, vendor managed inventory, radio frequency identification asset management, gearbox and fluid power assembly and repair, process pump assembly and repair, drive shaft repair, electrical panel assembly and repair, and hose and gasket manufacture and assembly services. The company was incorporated in 1928 and is headquartered in Atlanta, Georgia.

Genuine Parts Company

Goldman Sachs analyst Corinne Johnson maintained a Buy rating on Structure Therapeutics, Inc. Sponsored ADR yesterday and set a price target of $10...

Structure Therapeutics, Inc. Sponsored ADR (GPCR) Gets a Buy from Goldman Sachs

If steady portfolio income is a priority in 2026, dividend aristocrat stocks can be a strong way to lock in reliable cash returns. Which Dividend A...

3 Best Dividend Aristocrat Stocks to Buy Now, 01/16/2026

BMO Capital analyst Evan Seigerman maintained a Buy rating on Structure Therapeutics, Inc. Sponsored ADR on January 2 and set a price target of $13...

Current Quarter	$1.79	Next Quarter	$1.99
Current Year	$7.62	Next Year	$8.4
QoQ Growth	+11.2%	YoY Growth	+10.2%
3Y EPS CAGR	+1.2%	Target Price	$149.44
Consensus	Buy	Upside	+4.7%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	GPC	$142.72	+1.03%	802.34K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	GPC	$142.72	+1.0%	802.34K
3
4
5
6

GPC

GPC

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Genuine Parts Company Data in Excel

Get Genuine Parts Company Data in Excel